Anna Uryga is a Department Manager at Novo Nordisk with a focus on vascular biology in cardiometabolic diseases. In their previous roles as a Specialist & Scientific Lead in Cardiovascular Research and Senior Scientist, Anna was responsible for proposing and advancing early-stage targets within the cardiovascular therapeutic area, managing project teams, and establishing in vitro assays related to vascular health. Prior to their work at Novo Nordisk, Anna worked as a Postdoctoral Research Fellow at the University of Cambridge after completing their Doctor of Philosophy degree in Biomedical Sciences with a specialization in ageing and cardiovascular biology at Cardiff Metropolitan University.
This person is not in any teams
This person is not in any offices
Novo Nordisk
343 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.